This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07980/identifier/pdb/
n11http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB07980/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07980/identifier/pubchem-substance/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07980/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07980/identifier/chemspider/

Statements

Subject Item
n2:DB07980
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07980 n11:DB07980
dcterms:title
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine
adms:identifier
n9:77934 n10:DB07980 n12:99444451 n13:IM4 n14:86418
n3:IUPAC-Name
n4:271B5244-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B524A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5249-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5246-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5247-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5248-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5242-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5240-363D-11E5-9242-09173F13E4C5 n4:271B5243-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5241-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5250-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5251-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B524B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B524C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B524E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B524D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B524F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5256-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5258-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5259-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5255-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5254-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5257-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5245-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5252-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5253-363D-11E5-9242-09173F13E4C5